VTGN
Vistagen Therapeutics Inc.
$3.33
+$0.35(+11.74%)
72
Overall
--
Value
72
Tech
--
Quality
Market Cap
$89.28M
Volume
3.51M
52W Range
$1.90 - $3.88
Target Price
$13.00
EPS Estimates Overview
| Current Quarter | $-0.52 | Next Quarter | $-0.36 |
| Current Year | $-1.67 | Next Year | $-1.9 |
| QoQ Growth | +30.8% | YoY Growth | -13.8% |
| 3Y EPS CAGR | +39.4% | Target Price | $13.00 |
| Consensus | Buy | Upside | +290.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VTGN | $3.33 | +11.7% | 3.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vistagen Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW